PO.IM01.06 · 免疫学
CAR T Cell Functional Enhancement
-
4266 · PDF 使用特异性多聚体监测CAR-T细胞:一种快速、特异且可实现统一评估的方法 CAR-T-cell monitoring using specific multimers: a fast and specific method allowing uniform evaluation Elizabeth Epps, Kivin Jacobsen, kevin Lenogue, Liselotte Brix
-
4267 · PDF 在PBMC人源化SDKO小鼠中对自体抗BCMA CAR-T疗法的体内评估揭示供者特异性免疫反应 In vivo evaluation of autologous anti-BCMA CAR-T therapy in PBMC-humanized SDKO mice reveals donor-specific immune responses Alba Matas-Céspedes, Jiwon Yang, Kushal Prajapati, Destanie Rose, Oanh Pham, Michael Lehmann, Tom McKevitt, Georgina Cornish, Richard Stebbings, James G. Keck, Ilian Radichev
-
4268 · PDF 表达多功能B7-H3嵌合抗原受体的装甲型同种异体EB病毒特异性T细胞在实体瘤模型中表现出改善的持久性、扩增和性能 Armored allogeneic Epstein-Barr virus specific T cells expressing a multi-functional B7-H3 chimeric antigen receptor exhibit improved persistence, expansion and performance in solid tumor models Marvin Chew, Pei Yun Teo, Joanna Koh, Jin Wei Tan, Lindsay Kua, Richard Ong, Fiona Wong, Angeline Goh, Qingfeng Chen, Cliona Rooney, Ivan Horak, Kar Wai Tan, Lionel Low
-
4269 · PDF 用于治疗胰腺癌的靶向GPC1纳米抗体CAR T细胞的结构导向蛋白质工程与人源化 Structure-guided protein engineering and humanization of GPC1-targeted nanobody CAR T cells for treating pancreatic cancer Hsi En Tsao, Mitchell Ho
-
4270 · PDF 使用IF-BETTER门控CAR T细胞增强实体瘤排斥以治疗肝细胞癌 Enhanced solid tumor rejection using IF-BETTER gated CAR T cells for the treatment of hepatocellular carcinoma Leena Halim, Michael Lopez, Michel Sadelain
- 4272 4272 谷氨酸-草酰乙酸转氨酶2(GOT2)作为CAR-T细胞代谢适能的双功能增强剂 Glutamic-oxaloacetic transaminase 2 (GOT2) as a dual-functional enhancer for CAR-T cell metabolic fitness Xiangyi Fang, Shadab Kazmi, Andre Kelly, Xiaoling Jin, Alison Jaccard, Nathaniel W. Snyder, Alexander A. Shestov, Saba Ghassemi, Roddy S. O'Connor
- 4273 4273 CD19-CAR T细胞制造过程中的环境调控在皮下NALM6肿瘤模型中影响抗肿瘤效力 Environmental conditioning during CD19-CAR T cell manufacturing impacts antitumor potency in a subcutaneous NALM6 tumor model Candy Garcia, Anita J. Zaitouna, Abriel Czachorowski, Lauren Kucharczyk, Natalie Czeryba, Philip Edward Lapinski, Andrea Hodgins-Davis, Thomas Sullivan, Yelena Bronevetsky, NINGCHUN LIU, Sheri Barnes, Shannon Eaker, Scott Wise, James Lim
-
4274 · PDF 具有GPC3诱导型基因线路的CAR-T细胞用于靶向肝细胞癌 CAR-T cells with GPC3-inducible gene circuits for targeting hepatocellular carcinoma Kin Ching Tsang, Yuqing Deng, Pinghui Zhu, Chenzi Zhang, Jianwei Ren, Bo Feng
-
4275 · PDF 结合环状RNA与基于硅膜的细胞工程方法制造具有膜结合IL-2和IL-12的CAR-T细胞 Combining circular RNA and a silicon membrane-based cell engineering approach to create CAR-Ts with membrane bound IL-2 and IL-12 Armon Sharei, Zhihui Song, Sophia Hirsch, Eleni Rogers, Darby Kreienberg, Alec Barclay, Andrew Larocque, Anil Narasimha
-
4276 · PDF Synecta™ T1细胞衍生纳米颗粒与Flowfect®连续流转染提升CD19靶向CAR-T细胞的非病毒工程化效率和制造可扩展性用于血液系统恶性肿瘤 Synecta™ T1 cell-derived nanoparticles and Flowfect® continuous flow transfection enhance non-viral engineering efficiency and manufacturing scalability of CD19-directed CAR-T cells for hematologic malignancies Chiquita Hanindya, Christopher Abraham, Maria Lai, Peter Keller, Kevin Gutshall
-
4277 · PDF AQP3 NOT门控减轻MSLN靶向CAR-T细胞在卵巢癌中致死性的靶向肿瘤外肺毒性 AQP3 NOT gating mitigates lethal on-target off-tumor pulmonary toxicity of MSLN-directed CAR-T cells in ovarian cancer Minghua Xiang, Wei Mu, Bingbing Zhao, Jundong Li, Qinglei Gao, Huayi Li
-
4278 · PDF 受调节性T细胞启发的CAR-T细胞工程化增强实体瘤中的抗肿瘤疗效 Regulatory T cell inspired engineering of CAR-T cells enhances anti-tumor efficacy in solid tumors Avik Chattopadhyay, Erin O’Connor, Leonardo M. R. Ferreira
- 4279 4279 采用CD16A信号结构域工程化的PSMA靶向CAR-T细胞在前列腺癌模型中减少细胞因子输出同时保留抗肿瘤活性 A PSMA-targeted CAR-T cell engineered with a CD16A signaling domain mitigates cytokine output while retaining antitumor activity in prostate cancer models Parv Barot, Hittu Matta, Sunju Choi, Gong Songjie, Bryant Bravo, Elton Zho, Hsing-Yu Wu, Sam Lin, Zhuoyue Yang, Preet M. Chaudhary
-
4280 · PDF 通过ALA-CART平台恢复LAT信号促进AML CAR T细胞的代谢韧性和持久性 Restoration of LAT signaling via the ALA-CART platform promotes metabolic resiliency and persistence of AML CAR T cells Catherine Danis, Amanda J. Novak, Etienne Danis, Angie Vazquez, Michael Yarnell, Lillie Leach, M. Eric Kohler
-
4281 · PDF 用IL18武装ROR1 CAR T细胞可在体外和体内改善CAR T细胞针对胰腺癌细胞系的功能和细胞毒性 Armoring ROR1 CAR T cells with IL18 improves CAR T cell function and cytotoxicity against pancreatic cancer cell-lines in vitro and in vivo Bal Krishna Chand Thakuri, Saule Nurmukhambetova, Tri Tran, Ngoc Tran, Peirong Hu, Pradyot Dash, Rimas J Orentas, Alun Carter
-
4283 · PDF CD3阳性的异体CAR T细胞:一种具有持久性、BiTE捕获能力且无同种异体反应性的新型平台 CD3-positive allogeneic CAR T-cells: A novel platform with persistence, BiTE-capture, and no alloreactivity Tanya Hundal, Yan Luo, Yaqing Qie, Martha E. Gadd, Shaohua Guo, Mohamed A. Kharfan-Dabaja, Hong Qin
-
4284 · PDF FT839:一种新一代即用型CAR T细胞,独特地设计有靶向CD19和CD38的双CAR系统,用于在无预处理化疗的情况下治疗血液系统恶性肿瘤和自身免疫性疾病 FT839: A next-generation, off-the-shelf CAR T cell uniquely engineered with a dual CAR system targeting CD19 and CD38 for the treatment of hematological malignancies and autoimmune diseases without conditioning chemotherapy Alex J. Garcia, Shilpi Chandra, Soheila Shirinbak, Mark Jelcic, Brian Groff, Spas Markov, Alma Gutierrez, Angela Gentile, Miguel Meza, Karina Palomares, Carissa Dege, Bjoern Gaertner, Ramzey Abujarour, John Goulding, Tom Lee, Karl-Johan Malmberg, Maksim Mamonkin, Jode Goodridge, Martin Hosking
-
4286 · PDF B7-H3低免疫原性嵌合抗原受体T细胞可克服免疫排斥并保持针对胆管癌的抗肿瘤活性 B7-H3 hypoimmune chimeric antigen receptor T cells overcome immune rejection and retain antitumor activity against cholangiocarcinoma Chiara Camillo, Xiaomeng Hu, Giulia Cattaneo, Liti Zhang, Erica Daniels, Luigi Liguori, Eduardo Tejeda-Polanco, Maoyang Qi, Enrica Quattrocchi, Francesco Sabbatino, Sonja Schrepfer, Cristina R. Ferrone
-
4287 · PDF 在活CellCage封闭腔中测定工程化T细胞的杀伤动力学与异质性 Cell killing dynamics and heterogeneity in engineered T-cells measured in live CellCage enclosures Shawn Levy, Richard Yau, Shreya Deshmukh, JangKeun Kim, Jiwoon Park, Yanping Yang, Makenzie Sacca, Shan Sabri, Christopher E. Mason, Moonsoo M. Jin
-
4288 · PDF 使用50标志物质谱流式胞内细胞因子染色panel揭示细胞治疗产品中未曾预见的功能多样性并揭露潜在的疗效“破坏者” Use of a 50-marker mass cytometry intracellular cytokine staining panel reveals unforeseen functional diversity within cell therapy products and unmasks potential efficacy 'saboteurs' Lauren Tracey, Michael Cohen, Laura Polanco, Erika Smith-Mahoney, David King, Amedeo Cappione, Anna Belkina, Christina Loh, Jennifer E. Snyder-Cappione
-
4290 · PDF 利用优化的细胞治疗平台治疗ALK表达的儿童及成人实体瘤 Harnessing an optimized cellular therapy platform for ALK-expressing pediatric and adult solid tumors Alberto D. Guerra, Geoffrey Rouin, Patrick Ryan, Grant Li, David Groff, Christina Acholla, Matthew Beasley, Lauren A. Pitt, Kayla Hallac, Evan W. Weber, Yael P. Mosse
-
4291 · PDF Synecta™ T1细胞来源纳米颗粒实现加速、强效的T细胞扩增,用于可扩展的过继性免疫治疗制造 Synecta™ T1 cell-derived nanoparticles enable accelerated, potent T cell expansion for scalable adoptive immunotherapy manufacturing Deeksha Muthumani, Chiquita Hanindya, Gil Joseph, Victor Carpio, Bakir Valentić, Roddy O' Connor, Olga Barreiro, Ulrich H. Von Andrian, Peter Keller